HPLC/UV or bioassay: two valid methods for posaconazole quantification in human serum samples

In this paper we report on the development and validation of two different methods for posaconazole quantification from serum samples, HPLC/UV and bioassay. Both methods have been validated according to international guidelines and were also applied to the analysis of 61 trough serum samples from tr...

Full description

Saved in:
Bibliographic Details
Published in:Clinical microbiology and infection Vol. 18; no. 12; pp. 1229 - 1235
Main Authors: Cendejas-Bueno, E., Forastiero, A., Rodriguez-Tudela, J.L., Cuenca-Estrella, M., Gomez-Lopez, A.
Format: Journal Article
Language:English
Published: Oxford, UK Elsevier Ltd 01-12-2012
Blackwell Publishing Ltd
Wiley-Blackwell
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this paper we report on the development and validation of two different methods for posaconazole quantification from serum samples, HPLC/UV and bioassay. Both methods have been validated according to international guidelines and were also applied to the analysis of 61 trough serum samples from treated patients. A good correlation between both methods was observed. The HPLC method, more laborious and expensive, was demonstrated to be more accurate, precise and faster (analytical range 0.125-16 μg/mL, accuracy between -2.48 and 3.70% and precision between 2.77 and 5.93%, with an analytical run time of 11 min), making it a valuable tool for reference laboratories that centralize high numbers of samples. The microbiological method, however, is simple and offers sufficient precision and accuracy (analytical range 0.125-16 μg/mL, accuracy between -8.10 and 3.77% and a precision between 4.52 and 10.07%), to be used to monitor posaconazole. It may be a valid alternative to chromatographic methods in clinical laboratories without specialized facilities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1198-743X
1469-0691
DOI:10.1111/j.1469-0691.2011.03732.x